NasdaqGM - Delayed Quote USD
Structure Therapeutics Inc. (GPCR)
At close: November 20 at 4:00 PM EST
Pre-Market: 9:03 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
142,161.00
102,775.00
52,561.00
37,696.00
15,906.00
Operating Income
-142,161.00
-102,775.00
-52,561.00
-37,696.00
-15,906.00
Net Non Operating Interest Income Expense
31,473.00
13,391.00
1,257.00
-122.00
168.00
Pretax Income
-110,688.00
-89,384.00
-51,304.00
-37,818.00
-15,738.00
Tax Provision
-138.00
236.00
17.00
231.00
138.00
Net Income Common Stockholders
-110,550.00
-89,620.00
-52,836.00
-43,765.00
-16,039.00
Diluted NI Available to Com Stockholders
-110,550.00
-89,620.00
-52,836.00
-43,765.00
-16,039.00
Basic EPS
-2.16
-2.43
-1.38
-1.72
-0.64
Diluted EPS
-2.16
-2.43
-1.38
-1.72
-0.64
Basic Average Shares
49,894.42
36,732.67
38,243.18
25,482.17
25,053.10
Diluted Average Shares
49,894.42
36,732.67
38,243.18
25,482.17
25,053.10
Total Operating Income as Reported
-142,161.00
-102,775.00
-52,561.00
-37,696.00
-15,906.00
Total Expenses
142,161.00
102,775.00
52,561.00
37,696.00
15,906.00
Net Income from Continuing & Discontinued Operation
-110,550.00
-89,620.00
-51,321.00
-40,008.00
-15,876.00
Normalized Income
-110,550.00
-89,620.00
-51,321.00
-40,008.00
-15,876.00
Net Interest Income
31,473.00
13,391.00
1,257.00
-122.00
168.00
EBIT
-142,161.00
-102,775.00
-52,561.00
-37,696.00
-15,906.00
EBITDA
-141,370.00
-102,480.00
-52,284.00
-37,624.00
-15,906.00
Reconciled Depreciation
791.00
295.00
277.00
72.00
--
Net Income from Continuing Operation Net Minority Interest
-110,550.00
-89,620.00
-51,321.00
-40,008.00
-15,876.00
Normalized EBITDA
-141,370.00
-102,480.00
-52,284.00
-37,624.00
-15,906.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 2/3/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TERN Terns Pharmaceuticals, Inc.
5.60
-5.25%
MDGL Madrigal Pharmaceuticals, Inc.
317.09
+0.93%
CYTK Cytokinetics, Incorporated
49.86
-2.41%
APLS Apellis Pharmaceuticals, Inc.
27.49
-5.17%
BBIO BridgeBio Pharma, Inc.
23.04
+2.22%
ALT Altimmune, Inc.
8.05
+7.76%
APGE Apogee Therapeutics, Inc.
45.04
-3.18%
KYTX Kyverna Therapeutics, Inc.
4.1200
+0.98%
PTGX Protagonist Therapeutics, Inc.
40.65
+5.17%
VKTX Viking Therapeutics, Inc.
51.53
+0.04%